Vaxxas developed nanopatch vaccines: vaccines without needles. Nanoparticles inside a nanofibre patch apply the vaccine to the immune cells in the skin directly. Research shows that the technique is efficient and effective and reduces risk of infections. A very promising technology, especially for people with fear of needles. Vaxxas also uses a dry-coating, ensuring that the vaccines require no or less refrigeration during storage and transportation. The technique thus simplifies logistics in addition to helping patients.
